Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis.

Schizophrenia Research
Zixuan WangR Brauer


To investigate whether exposure to antipsychotic medications during pregnancy is associated with gestational diabetes mellitus (GDM) in United Kingdom (UK) and Hong Kong (HK) population cohorts. Two population-based cohort studies were conducted using data from the UK The Health Improvement Network (THIN) and HK Clinical Data Analysis and Reporting System (CDARS). Nondiabetic women who received any type of antipsychotic medicine before their first pregnancy were included in our cohorts. The exposed group comprised women who continued using antipsychotics from the start of pregnancy to delivery (continuers), while the comparison group included women who were prescribed antipsychotics before the start of pregnancy but stopped during pregnancy (discontinuers). GDM was identified using GDM diagnosis and/or clinicians reported GDM. Odds ratios (ORs) with a 95% confidence interval (CI) were calculated to assess the association between antipsychotic use during pregnancy and GDM. Propensity Score fine-stratification weighting was used to adjust for potential confounding factors. 3114 women with registered first pregnancies (2351 in THIN and 763 in CDARS) were included. 5.49% (2.55% in THIN and 14.55% in CDARS) were diagnosed with GDM. ...Continue Reading


Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Dec 25, 2003·Diabetes Care·UNKNOWN American Diabetes Association
Feb 11, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paola DazzanRobin M Murray
May 16, 2008·Journal of Clinical Psychopharmacology·Margareta Reis, Bengt Källén
Sep 8, 2010·Archives of Pediatrics & Adolescent Medicine·Shreya DavéIrwin Nazareth
Jun 16, 2012·Indian Journal of Endocrinology and Metabolism·Angadi Rajasab NiloferSyed Ahmed Zaki
Jul 4, 2012·Archives of General Psychiatry·Robert BodénHelle Kieler
Oct 2, 2012·Annual Review of Medicine·Herbert Y Meltzer
Nov 6, 2012·Pharmacoepidemiology and Drug Safety·Laura HorsfallIrene Petersen
Aug 31, 2014·Schizophrenia Research·Irene PetersenIrwin Nazareth
May 15, 2015·BMJ : British Medical Journal·Hind KhalifehLouise M Howard
Sep 10, 2015·European Journal of Clinical Nutrition·E A TryggvadottirI Gunnarsdottir
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Wallis C Y LauIan C K Wong
Jun 3, 2017·Statistical Methods in Medical Research·Clémence LeyratElizabeth J Williamson
Aug 16, 2017·Journal of Psychiatric Research·Alice PanchaudLee S Cohen
May 8, 2018·The American Journal of Psychiatry·Yoonyoung ParkKrista F Huybrechts
Feb 1, 2019·Frontiers in Psychiatry·Antonio VentriglioAntonello Bellomo
Feb 9, 2019·Diabetology & Metabolic Syndrome·Samira Behboudi-GandevaniFahimeh Ramezani Tehrani
Apr 17, 2020·Schizophrenia Research·Johan ReutforsGabriella Bröms

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.